BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8943397)

  • 1. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.
    Zamorano J; Wang HY; Wang LM; Pierce JH; Keegan AD
    J Immunol; 1996 Dec; 157(11):4926-34. PubMed ID: 8943397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells.
    Izuhara K; Harada N
    Biochem Biophys Res Commun; 1996 Dec; 229(2):624-9. PubMed ID: 8954948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cells.
    Fantin VR; Keller SR; Lienhard GE; Wang LM
    Biochem Biophys Res Commun; 1999 Jul; 260(3):718-23. PubMed ID: 10403832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
    Tanaka S; Wands JR
    Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
    Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP
    Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
    Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
    J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H; Tu X; Liu M; Baserga R
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
    Minshall C; Arkins S; Freund GG; Kelley KW
    J Immunol; 1996 Feb; 156(3):939-47. PubMed ID: 8558020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction through the IL-4 and insulin receptor families.
    Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
    Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal.
    Zhou-Li F; Xu SQ; Dews M; Baserga R
    Oncogene; 1997 Aug; 15(8):961-70. PubMed ID: 9285691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
    Carey GB; Semenova E; Qi X; Keegan AD
    Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Chen RH; Su YH; Chuang RL; Chang TY
    Oncogene; 1998 Oct; 17(15):1959-68. PubMed ID: 9788439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine-rich region of the IL-2 receptor beta-chain is required for activation of phosphatidylinositol 3-kinase.
    Kanazawa T; Keeler ML; Varticovski L
    Cell Immunol; 1994 Jul; 156(2):378-88. PubMed ID: 8025955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation.
    Myers MG; Grammer TC; Wang LM; Sun XJ; Pierce JH; Blenis J; White MF
    J Biol Chem; 1994 Nov; 269(46):28783-9. PubMed ID: 7961833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin secretion and phosphorylation of common proteins are induced by IL-2, IL-4, and IL-6 in the factor responsive human B cell line, SKW6.4.
    Goldstein H; Kim A
    J Immunol; 1993 Dec; 151(12):6701-11. PubMed ID: 8258686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors.
    Laneuville P; Timm M; Hudson AT
    Cancer Res; 1994 Mar; 54(5):1360-6. PubMed ID: 8118826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.